Anti-inflammatory dimethylfumarate: A potential new therapy for asthma?

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Seidel, Petra ^a   Roth, Michael ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DIMETHYLFUMARATE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; UNCLASSIFIED DRUG; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CELL PROLIFERATION; HUMAN; IN VITRO STUDY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SMOOTH MUSCLE FIBER; DRUG EFFECT; METABOLISM; DRUG EFFECTS;

ANTI-INFLAMMATORY AGENTS; ASTHMA; FUMARATES; HUMANS; MYOCYTES, SMOOTH MUSCLE;

EID: 84876520591     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/875403     Document Type: Review

References (110)

1. Holgate S. T., Innate and adaptive immune responses in asthma. Nature Medicine 2012 18 5 673 683 10.1038/nm.2731
2. Mullane K., The increasing challenge of discovering asthma drugs. Biochemical Pharmacology 2011 82 6 586 599 10.1016/j.bcp.2011.06.033
3. Stevenson C. S., Birrell M. A., Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacology and Therapeutics 2011 130 2 93 105 2-s2.0-79953663682 10.1016/j.pharmthera.2010.10. 008
4. Bossley C. J., Fleming L., Gupta A., Regamey N., Frith J., Oates T., Tsartsali L., Lloyd C. M., Bush A., Saglani S., Pediatric severe asthma is characterized by eosinophilia and remodeling without T H 2 cytokines. Journal of Allergy and Clinical Immunology 2012 129 4 974 982 10.1016/j.jaci.2012.01.059
5. Grainge C. L., Lau L. C. K., Ward J. A., Dulay V., Lahiff G., Wilson S., Holgate S., Davies D. E., Howarth P. H., Effect of bronchoconstriction on airway remodeling in asthma. The New England Journal of Medicine 2011 364 21 2006 2015 2-s2.0-79957512933 10.1056/NEJMoa1014350
6. James A. L., Elliot J. G., Jones R. L., Carroll M. L., Mauad T., Bai T. R., Abramson M. J., McKay K. O., Green F. H., Airway smooth muscle hypertrophy and hyperplasia in asthma. American Journal of Respiratory and Critical Care Medicine 2012 185 10 1058 1064
7. O'Reilly R., Ullmann N., Irving S., Bossley C. J., Sonnappa S., Zhu J., Oates T., Banya W., Jeffery P. K., Bush A., Saglani S., Increased airway smooth muscle in preschool wheezers who have asthma at school age. Journal of Allergy and Clinical Immunology 2012 10.1016/j.jaci.2012.08.044
8. Huber H. L., Koessler K. K., The pathology of bronchial asthma. Archives of Internal Medicine 1922 30 689 760
9. Ramos-Barbón D., Fraga-Iriso R., Brienza N. S., Montero-Martínez C., Verea-Hernando H., Olivenstein R., Lemiere C., Ernst P., Hamid Q. A., Martin J. G., T cells localize with proliferating smooth muscle α -actin+ cell compartments in asthma. American Journal of Respiratory and Critical Care Medicine 2010 182 3 317 324 2-s2.0-77956635183 10.1164/rccm.200905-0745OC
10. Lambrecht B. N., Hammad H., The airway epithelium in asthma. Nature Medicine 2012 18 5 684 692
11. Tran M. U. T., Weir A. J., Fanucchi M. V., Rodriguez A. E., Pantle L. M., Smiley-Jewell S. M., Van Winkle L. S., Evans M. J., Miller L. A., Schelegle E. S., Gershwin L. J., Hyde D. M., Plopper C. G., Smooth muscle hypertrophy in distal airways of sensitized infant rhesus monkeys exposed to house dust mite allergen. Clinical and Experimental Allergy 2004 34 10 1627 1633 2-s2.0-6344294763 10.1111/j.1365-2222.2004.02057.x (Pubitemid 39389342)
12. Plopper C. G., Smiley-Jewell S. M., Miller L. A., Fanucchi M. V., Evans M. J., Buckpitt A. R., Avdalovic M., Gershwin L. J., Joad J. P., Kajekar R., Larson S., Pinkerton K. E., Van Winkle L. S., Schelegle E. S., Pieczarka E. M., Wu R., Hyde D. M., Asthma/allergic airways disease: does postnatal exposure to environmental toxicants promote airway pathobiology? Toxicologic Pathology 2007 35 1 97 110 2-s2.0-33847256332 10.1080/01926230601132030 (Pubitemid 46328410)
13. Wahidi M. M., Kraft M., Bronchial thermoplasty for severe asthma. American Journal of Respiratory and Critical Care Medicine 2012 185 7 709 714
14. Janssen L. J., Airway smooth muscle as a target in asthma and the beneficial effects of bronchial thermoplasty. Journal of Allergy 2012 2012 9 593784 10.1155/2012/593784
15. Doeing D. C., Mahajan A. K., White S. R., Naureckas E. T., Krishnan J. A., Hogarth D. K., Safety and feasibility of bronchial thermoplasty in asthma patients with very severe fixed airflow obstruction: a case series. Journal of Asthma 2012 50 2 215 218 10.3109/02770903.2012.751997
16. Brightling C. E., Bradding P., Symon F. A., Holgate S. T., Wardlaw A. J., Pavord I. D., Mast-cell infiltration of airway smooth muscle in asthma. The New England Journal of Medicine 2002 346 22 1699 1705 2-s2.0-0037198418 10.1056/NEJMoa012705 (Pubitemid 34547483)
17. Carnieli D. S., Yoshioka E., Silva L. F. F., Lanças T., Arantes F. M., Perini A., Martins M. A., Saldiva P. H. N., Dolhnikoff M., Mauad T., Inflammation and remodeling in infantile, juvenile, and adult allergic sensitized mice. Pediatric Pulmonology 2011 46 7 650 665 2-s2.0-79959845443 10.1002/ppul.21436
18. Black J. L., Panettieri R. A. Jr., Banerjee A., Berger P., Airway smooth muscle in asthma: just a target for bronchodilation? Clinics In Chest Medicine 2012 33 3 543 558
19. Stewart A., More muscle in asthma, but where did it come from? American Journal of Respiratory and Critical Care Medicine 2012 185 10 1035 1037
20. Adcock I. M., Ford P. A., Bhavsar P., Ahmad T., Chung K. F., Steroid resistance in asthma: mechanisms and treatment options. Current Allergy and Asthma Reports 2008 8 2 171 178 2-s2.0-42149156064 10.1007/s11882-008-0028-4 (Pubitemid 351524105)
21. Bond K., Spooner C., Tjosvold L., Lemière C., Rowe B. H., The nature and influence of pharmaceutical industry involvement in asthma trials. Canadian Respiratory Journal 2012 19 4 267 271
22. Nakamura Y., Developmental current and future therapy for severe asthma. Inflammation and Allergy Drug Targets 2012
23. Siddiqui S., Redhu N. S., Ojo O. O., Liu B., Irechukwu N., Billington C., Janssen L., Moir L. M., Emerging airway smooth muscle targets to treat asthma. Pulmonary Pharmacology & Therapeutics 2012 5539 12 1094 10. 10.1016/j.pupt.2012.08.008
24. Meissner M., Valesky E. M., Kippenberger S., Kaufmann R., Dimethyl fumarate-only an anti-psoriatic medication? Journal der Deutschen Dermatologischen Gesellschaft 2012 10 11 793 801
25. Alrashdan Y. A., Alkhouri H., Chen E., Lalor D. J., Poniris M., Henness S., Brightling C. E., Burgess J. K., Armour C. L., Ammit A. J., Hughes J. M., Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. American Journal of Physiology 2012 302 10 L1118 L1127
26. Seidel P., Merfort I., Hughes J. M., Oliver B. G. G., Tamm M., Roth M., Dimethylfumarate inhibits NF- B function at multiple levels to limit airway smooth muscle cell cytokine secretion. American Journal of Physiology 2009 297 2 L326 L339 2-s2.0-67651236354 10.1152/ajplung.90624.2008
27. Seidel P., Hostettler K., Hughes J., Tamm M., Roth M., Dimethylfumarate inhibits CXCL10 via heme-oxygenase-1 in airway smooth muscle. European Respiratory Journal 2013 41 1 195 202
28. Seidel P., Merfort I., Tamm M., Roth M., Inhibition of NF- B and AP-1 by dimethylfumarate correlates with down-regulated IL-6 secretion and proliferation in human lung fibroblasts. Swiss Medical Weekly 2010 140 w13132 2-s2.0-79952200120
29. Woodman L., Siddiqui S., Cruse G., Sutcliffe A., Saunders R., Kaur D., Bradding P., Brightling C., Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF- β 1. Journal of Immunology 2008 181 7 5001 5007 2-s2.0-58149280835
30. Berger P., Perng D. W., Thabrew H., Compton S. J., Cairns J. A., McEuen A. R., Marthan R., Tunon De Lara J. M., Walls A. F., Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. Journal of Applied Physiology 2001 91 3 1372 1379 2-s2.0-0034867321 (Pubitemid 32803935)
31. Berger P., Girodet P. O., Begueret H., Ousova O., Perng D. W., Marthan R., Walls A. F., Tunon de Lara J. M., Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. The FASEB Journal 2003 17 14 2139 2141 2-s2.0-0642364966
32. Lazaar A. L., Albelda S. M., Pilewski J. M., Brennan B., Puré E., Panettieri R. A., T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. Journal of Experimental Medicine 1994 180 3 807 816 2-s2.0-0027994066 10.1084/jem.180.3.807 (Pubitemid 24256594)
33. Brightling C. E., Ammit A. J., Kaur D., Black J. L., Wardlaw A. J., Hughes J. M., Bradding P., The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. American Journal of Respiratory and Critical Care Medicine 2005 171 10 1103 1108 2-s2.0-18644380441 10.1164/rccm.200409-1220OC (Pubitemid 40663721)
34. Carroll N. G., Mutavdzic S., James A. L., Distribution and degranulation of airway mast cells in normal and asthmatic subjects. European Respiratory Journal 2002 19 5 879 885 2-s2.0-0036014530 10.1183/09031936.02.00275802 (Pubitemid 34567902)
35. Seidel P., Roth M., Ge Q., Merfort I., S'ng C. T., Ammit A. J., I B α glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES. European Respiratory Journal 2011 38 6 1444 1452 10.1183/09031936.00129610
36. Seidel P., Goulet S., Hostettler K., Tamm M., Roth M., DMF inhibits PDGF-BB induced airway smooth muscle cell proliferation through induction of heme-oxygenase-1. Respiratory Research 2010 11, article 145 2-s2.0-77958010498 10.1186/1465-9921-11-145
37. 2 agonists, corticosteroids, and novel therapies on rhinovirus-induced cytokine release and rhinovirus replication in primary airway fibroblasts. Journal of Allergy 2011 2011 11 457169 10.1155/2011/457169
38. Lalor D. J., Truong B., Henness S., Blake A. E., Ge Q., Ammit A. J., Armour C. L., Hughes J. M., Mechanisms of serum potentiation of GM-CSF production by human airway smooth muscle cells. American Journal of Physiology 2004 287 5 L1007 L1016 2-s2.0-6344235007 10.1152/ajplung.00126.2004 (Pubitemid 39391031)
39. Clarke D. L., Clifford R. L., Jindarat S., Proud D., Pang L., Belvisi M., Knox A. J., TNF α and IFN γ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF- B, and the transcriptional coactivator CREB-binding protein. Journal of Biological Chemistry 2010 285 38 29101 29110 2-s2.0-77956547990 10.1074/jbc.M109.0999952
40. Hardaker E. L., Bacon A. M., Carlson K., Roshak A. K., Foley J. J., Schmidt D. B., Buckley P. T., Comegys M., Panettieri R. A., Sarau H. M., Belmonte K. E., Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. The FASEB Journal 2004 18 1 191 193 2-s2.0-1342310784
41. Seidel P., Alkhouri H., Lalor D. J., Burgess J. K., Armour C. L., Hughes J. M., Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies. Respiratory Research 2012 13 90
42. Trian T., Benard G., Begueret H., Rossignol R., Girodet P. O., Ghosh D., Ousova O., Vernejoux J. M., Marthan R., Tunon-De-Lara J. M., Berger P., Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. Journal of Experimental Medicine 2007 204 13 3173 3181 2-s2.0-37549041957 10.1084/jem.20070956
43. Borger P., Miglino N., Baraket M., Black J. L., Tamm M., Roth M., Impaired translation of CCAAT/enhancer binding protein α mRNA in bronchial smooth muscle cells of asthmatic patients. Journal of Allergy and Clinical Immunology 2009 123 3 639 645 2-s2.0-61649127081 10.1016/j.jaci.2008.11.006
44. Coleman J. M., Naik C., Holguin F., Ray A., Ray P., Trudeau J. B., Wenzel S. E., Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset. Thorax 2012 67 1061 1066
45. Lee Y. J., Kim K. W., Choi B. S., Sohn M. H., Kim K. E., Clinical characteristics of eosinophilic and noneosinophilic asthma in children. Acta Paediatrica 2012 102 1 53 57 10.1111/apa.12046
46. Rosenberg H. F., Dyer K. D., Foster P. S., Eosinophils: changing perspectives in health and disease. Nature Reviews Immunology 2012 13 1 9 22 10.1038/nri3341
47. Ghaffar O., Hamid Q., Renzi P. M., Allakhverdi Z., Molet S., Hogg J. C., Shore S. A., Luster A. D., Lamkhioued B., Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. American Journal of Respiratory and Critical Care Medicine 1999 159 6 1933 1942 2-s2.0-0032991806 (Pubitemid 29275066)
48. Pepe C., Foley S., Shannon J., Lemiere C., Olivenstein R., Ernst P., Ludwig M. S., Martin J. G., Hamid Q., Differences in airway remodeling between subjects with severe and moderate asthma. Journal of Allergy and Clinical Immunology 2005 116 3 544 549 (Pubitemid 41267126)
49. Saunders R., Sutcliffe A., Woodman L., Kaur D., Siddiqui S., Okayama Y., Wardlaw A., Bradding P., Brightling C., The airway smooth muscle CCR3/CCL11 axis is inhibited by mast cells. Allergy 2008 63 9 1148 1155 2-s2.0-49249139614 10.1111/j.1398-9995.2008.01684.x
50. Chang P. J., Bhavsar P. K., Michaeloudes C., Khorasani N., Chung K. F., Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma. Journal of Allergy and Clinical Immunology 2012 130 4 877 885
51. Odaka M., Matsukura S., Kuga H., Kokubu F., Kasama T., Kurokawa M., Kawaguchi M., Ieki K., Suzuki S., Watanabe S., Homma T., Takeuchi H., Nohtomi K., Schleimer R. P., Adachi M., Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells. International Archives of Allergy and Immunology 2007 143 1 84 88 2-s2.0-34249828665 10.1159/000101412 (Pubitemid 46854799)
52. Chan V., Burgess J. K., Ratoff J. C., O'Connor B. J., Greenough A., Lee T. H., Hirst S. J., Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. American Journal of Respiratory and Critical Care Medicine 2006 174 4 379 385 2-s2.0-33747132952 10.1164/rccm.200509-1420OC (Pubitemid 44223117)
53. Halwani R., Al-Abri J., Beland M., Al-Jahdali H., Halayko A. J., Lee T. H., Al-Muhsen S., Hamid Q., CC and CXC chemokines induce airway smooth muscle proliferation and survival. Journal of Immunology 2011 186 7 4156 4163 2-s2.0-79955033457 10.4049/jimmunol.1001210
54. Schall T. J., Bacon K., Toy K. J., Goeddel D. V., Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990 347 6294 669 671 2-s2.0-0025038599 10.1038/347669a0 (Pubitemid 20356243)
55. Pang L., Nie M., Corbett L., Sutcliffe A., Knox A. J., Mast cell β -tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. Journal of Immunology 2006 176 6 3788 3795 2-s2.0-33644847416 (Pubitemid 43364027)
56. Berkman N., Krishnan V. L., Gilbey T., Newton R., O'Connor B., Barnes P. J., Chung K. F., Expression of RANTES mRNA and protein in airways of patients with mild asthma. American Journal of Respiratory and Critical Care Medicine 1996 154 6 1804 1811 2-s2.0-0030446293 (Pubitemid 26424954)
57. Oltmanns U., Issa R., Sukkar M. B., John M., Chung K. F., Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. British Journal of Pharmacology 2003 139 6 1228 1234 2-s2.0-0042168772 10.1038/sj.bjp.0705345 (Pubitemid 36920687)
58. Ammit A. J., Lazaar A. L., Irani C., O'Neill G. M., Gordon N. D., Amrani Y., Penn R. B., Panettieri R. A., Tumor necrosis factor- α -induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: Modulation by glucocorticoids and β -agonists. American Journal of Respiratory Cell and Molecular Biology 2002 26 4 465 474 2-s2.0-0036009461 (Pubitemid 34253931)
59. Kuo P. L., Hsu Y. L., Huang M. S., Chiang S. L., Ko Y. C., Bronchial epithelium-derived IL-8 and RANTES increased bronchial smooth muscle cell migration and proliferation by Krüppel-like factor 5 in areca nut-mediated airway remodeling. Toxicological Sciences 2011 121 1 177 190 2-s2.0-79955445335 10.1093/toxsci/kfr030
60. Chhabra J., Li Y. Z., Alkhouri H., Blake A. E., Ge Q., Armour C. L., Hughes J. M., Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release. European Respiratory Journal 2007 29 5 861 870 2-s2.0-34248175188 10.1183/09031936.00106306 (Pubitemid 46711889)
61. Schweckendiek W., Treatment of psoriasis vulgaris. Medizinische Monatsschrift 1959 13 2 103 104 2-s2.0-70449253356
62. Nieboer C., de Hoop D., Van Loenen A. C., Langendijk P. N. J., Van Dijk E., Systemic therapy with fumaric acid derivatives: New possibilities in the treatment of psoriasis. Journal of the American Academy of Dermatology 1989 20 4 601 608 2-s2.0-0024546807 (Pubitemid 19091258)
63. Harries M. J., Chalmers R. J. G., Griffiths C. E. M., Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. British Journal of Dermatology 2005 153 3 549 551 2-s2.0-24344443338 10.1111/j.1365-2133.2005. 06728.x (Pubitemid 41248211)
64. Nast A., Kopp I., Augustin M., Banditt K. B., Boehncke W. H., Follmann M., Friedrich M., Huber M., Kahl C., Klaus J., Koza J., Kreiselmaier I., Mohr J., Mrowietz U., Ockenfels H. M., Orzechowski H. D., Prinz J., Reich K., Rosenbach T., Rosumeck S., Schlaeger M., Schmid-Ott G., Sebastian M., Streit V., Weberschock T., Rzany B., German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Archives of Dermatological Research 2007 299 3 111 138 2-s2.0-34249693512 10.1007/s00403-007-0744-y (Pubitemid 46835379)
65. Yazdi M. R., Mrowietz U., Fumaric acid esters. Clinics in Dermatology 2008 26 5 522 526 2-s2.0-49849096362 10.1016/j.clindermatol.2008.07.001
66. Kappos L., Gold R., Miller D. H., MacManus D. G., Havrdova E., Limmroth V., Polman C. H., Schmierer K., Yousry T. A., Yang M., Eraksoy M., Meluzinova E., Rektor I., Dawson K. T., Sandrock A. W., O'Neill G. N., Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. The Lancet 2008 372 9648 1463 1472 2-s2.0-54149116366 10.1016/S0140-6736(08)61619-0
67. Fox R. J., Miller D. H., Phillips J. T., Hutchinson M., Havrdova E., Kita M., Yang M., Raghupathi K., Novas M., Sweetser M. T., Viglietta V., Dawson K. T., Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. The New England Journal of Medicine 2012 367 12 1087 1097
68. Gold R., Linker R. A., Stangel M., Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action. Clinical Immunology 2011 2-s2.0-79952558017 10.1016/j.clim.2011.02.017
69. Mrowietz U., Christophers E., Altmeyer P., Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use. British Journal of Dermatology 1999 141 3 424 429 2-s2.0-0032858530 10.1046/j.1365-2133.1999.03034.x (Pubitemid 29448401)
70. Mrowietz U., Christophers E., Altmeyer P., Treatment of psoriasis with fumaric acid esters: Results of a prospective multicentre study. British Journal of Dermatology 1998 138 3 456 460 2-s2.0-0031896129 10.1046/j.1365-2133.1998. 02124.x (Pubitemid 28145514)
71. Mrowietz U., Altmeyer P., Bieber T., Röcken M., Schopf R. E., Sterry W., Treatment of psoriasis with fumaric acid esters (Fumaderm). Journal of the German Society of Dermatology 2007 5 8 716 717 2-s2.0-34547129333 10.1111/j.1610-0387.2007.06346.x (Pubitemid 47099800)
72. Hoefnagel J. J., Thio H. B., Willemze R., Bouwes Bavinck J. N., Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. British Journal of Dermatology 2003 149 2 363 369 2-s2.0-0042413498 10.1046/j.1365-2133.2003.05433.x (Pubitemid 37100263)
73. Nieboer C., de Hoop D., Langendijk P. N. J., Van Loenen A. C., Gubbels J., Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester. Dermatologica 1990 181 1 33 37 2-s2.0-0025309310 (Pubitemid 20207396)
74. Litjens N. H., Burggraaf J., van Strijen E., van Gulpen C., Mattie H., Schoemaker R. C., van Dissel J. T., Thio H. B., Nibbering P. H., Pharmacokinetics of oral fumarates in healthy subjects. British Journal of Clinical Pharmacology 2004 58 4 429 432 (Pubitemid 39312467)
75. Vandermeeren M., Janssens S., Borgers M., Geysen J., Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells. Biochemical and Biophysical Research Communications 1997 234 1 19 23 2-s2.0-0030913951 10.1006/bbrc.1997.6570 (Pubitemid 27267523)
76. Gesser B., Johansen C., Rasmussen M. K., Funding A. T., Otkjaer K., Kjellerup R. B., Kragballe K., Iversen L., Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect. Journal of Investigative Dermatology 2007 127 9 2129 2137 2-s2.0-34547890303 10.1038/sj.jid.5700859 (Pubitemid 47258496)
77. Schmidt T. J., Ak M., Mrowietz U., Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-l-cysteine-Preparation of S-substituted thiosuccinic acid esters. Bioorganic and Medicinal Chemistry 2007 15 1 333 342 2-s2.0-33750930682 10.1016/j.bmc.2006.09.053 (Pubitemid 44738571)
78. Rostami-Yazdi M., Clement B., Schmidt T. J., Schinor D., Mrowietz U., Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action. The Journal of Investigative Dermatology 2009 129 1 231 234 2-s2.0-58149355788 10.1038/jid.2008.197
79. Reich K., Thaci D., Mrowietz U., Kamps A., Neureither M., Luger T., Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). Journal of the German Society of Dermatology 2009 7 7 603 611 2-s2.0-68149087714 10.1111/j.1610-0387.2009.07120.x
80. Treumer F., Zhu K., Gläser R., Mrowietz U., Dimethylfumarate is a potent inducer of apoptosis in human T cells. Journal of Investigative Dermatology 2003 121 6 1383 1388 2-s2.0-0345732760 10.1111/j.1523-1747.2003. 12605.x (Pubitemid 38005490)
81. Gerdes S., Shakery K., Mrowietz U., Dimethylfumarate inhibits nuclear binding of nuclear factor B but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein β in activated human T cells. British Journal of Dermatology 2007 156 5 838 842 2-s2.0-34247375995 10.1111/j.1365-2133.2007.07779.x (Pubitemid 46642827)
82. Höxtermann S., Nüchel C., Altmeyer P., Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 1998 196 2 223 230 2-s2.0-2642687679 10.1159/000017903 (Pubitemid 28139451)
83. Bovenschen H. J., Langewouters A. M. G., Van De Kerkhof P. C. M., Dimethylfumarate for psoriasis: pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study. American Journal of Clinical Dermatology 2010 11 5 343 350 2-s2.0-77954800370 10.2165/11533240-000000000-00000
84. Peng H., Guerau-de-Arellano M., Mehta V. B., Yang Y., Huss D. J., Papenfuss T. L., Lovett-Racke A. E., Racke M. K., Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor B (NF- B) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling. The Journal of Biological Chemistry 2012 287 33 28017 28026 10.1074/jbc.M112.383380
85. Stoof T. J., Flier J., Sampat S., Nieboer C., Tensen C. P., Boorsma D. M., The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. British Journal of Dermatology 2001 144 6 1114 1120 2-s2.0-0035725785 10.1046/j.1365-2133.2001.04220.x (Pubitemid 34204199)
86. Gesser B., Rasmussen M. K., Raaby L., Rosada C., Johansen C., Kjellerup R. B., Kragballe K., Iversen L., Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression. Inflammation Research 2011 60 7 643 553
87. Lehmann J. C. U., Listopad J. J., Rentzsch C. U., Igney F. H., Von Bonin A., Hennekes H. H., Asadullah K., Docke W. D. F., Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. Journal of Investigative Dermatology 2007 127 4 835 845 2-s2.0-33947265597 10.1038/sj.jid.5700686 (Pubitemid 46434667)
88. Loewe R., Holnthoner W., Gröger M., Pillinger M., Gruber F., Mechtcheriakova D., Hofer E., Wolff K., Petzelbauer P., Dimethylfumarate inhibits TNF-induced nuclear entry of NF- B/p65 in human endothelial cells. Journal of Immunology 2002 168 9 4781 4787 2-s2.0-0036569398 (Pubitemid 34441387)
89. Wallbrecht K., Drick N., Hund A. C., Schon M. P., Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. Experimental Dermatology 2011 20 12 980 985
90. Meissner M., Doll M., Hrgovic I., Reichenbach G., König V., Hailemariam-Jahn T., Gille J., Kaufmann R., Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action. Journal of Investigative Dermatology 2011 131 6 1356 1364 2-s2.0-79956001811 10.1038/jid.2011.46
91. Lee D. H., Gold R., Linker R. A., Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. International Journal of Molecular Sciences 1803 13 9 11783 11781 10.3390/ijms130911783
92. Schimrigk S., Brune N., Hellwig K., Lukas C., Bellenberg B., Rieks M., Hoffmann V., Pöhlau D., Przuntek H., Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. European Journal of Neurology 2006 13 6 604 610 2-s2.0-33745051595 10.1111/j.1468-1331.2006.01292.x (Pubitemid 43873632)
93. Gold R., Kappos L., Arnold D. L., Bar-Or A., Giovannoni G., Selmaj K., Tornatore C., Sweetser M. T., Yang M., Sheikh S. I., Dawson K. T., DEFINE Study Investigators. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. The New England Journal of Medicine 2012 367 12 1098 1107
94. Albrecht P., Bouchachia I., Goebels N., Henke N., Hofstetter H. H., Issberner A., Kovacs Z., Lewerenz J., Lisak D., Maher P., Mausberg A. K., Quasthoff K., Zimmermann C., Hartung H. P., Methner A., Effects of dimethyl fumarate on neuroprotection and immunomodulation. Journal of Neuroinflammation 2012 9 163
95. Lin S. X., Lisi L., Dello Russo C., Polak P. E., Sharp A., Weinberg G., Kalinin S., Feinstein D. L., The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro 2011 3 2 75 84 2-s2.0-79958153194 10.1042/AN20100033
96. Scannevin R. H., Chollate S., Jung M. Y., Shackett M., Patel H., Bista P., Zeng W., Ryan S., Yamamoto M., Lukashev M., Rhodes K. J., Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. Journal of Pharmacology and Experimental Therapeutics 2012 341 1 274 284
97. Hart L. A., Krishnan V. L., Adcock I. M., Barnes P. J., Chung K. F., Activation and localization of transcription factor, nuclear factor- B, in asthma. American Journal of Respiratory and Critical Care Medicine 1998 158 5 1585 1592 2-s2.0-0031731150
98. Catley M. C., Sukkar M. B., Chung K. F., Jaffee B., Liao S. M., Coyle A. J., Haddad E. B., Barnes P. J., Newton R., Validation of the anti-inflammatory properties of small-molecule I B kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Molecular Pharmacology 2006 70 2 697 705 2-s2.0-33746217403 10.1124/mol.106.023150 (Pubitemid 44092330)
99. Henderson W. R., Chi E. Y., Teo J. L., Nguyen C., Kahn M., A small molecule inhibitor of redox-regulated NF- B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. Journal of Immunology 2002 169 9 5294 5299 2-s2.0-0036839618 (Pubitemid 35217202)
100. Tergaonkar V., NF B pathway: a good signaling paradigm and therapeutic target. International Journal of Biochemistry and Cell Biology 2006 38 10 1647 1653 2-s2.0-33745342580 10.1016/j.biocel.2006.03.023 (Pubitemid 43947652)
101. Liao B. C., Hsieh C. W., Lin Y. C., Wung B. S., The glutaredoxin/ glutathione system modulates NF- B activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells. Toxicological Sciences 2010 116 1 151 163 2-s2.0-77954368172 10.1093/toxsci/kfq098
102. Kil I. S., Kim S. Y., Park J. W., Glutathionylation regulates I B. Biochemical and Biophysical Research Communications 2008 373 1 169 173
103. Cross S. A., Cook D. R., Chi A. W., Vance P. J., Kolson L. L., Wong B. J., Jordan-Sciutto K. L., Kolson D. L., Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. The Journal of Immunology 2011 187 10 5015 5025
104. Kirkham P., Rahman I., Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacology and Therapeutics 2006 111 2 476 494 2-s2.0-33744832661 10.1016/j.pharmthera.2005.10.015 (Pubitemid 43832007)
105. Wuyts W. A., Vanaudenaerde B. M., Dupont L. J., Demedts M. G., Verleden G. M., N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells. European Respiratory Journal 2003 22 1 43 49 2-s2.0-0042812457 (Pubitemid 36896469)
106. Brar S. S., Kennedy T. P., Sturrock A. B., Huecksteadt T. P., Quinn M. T., Murphy T. M., Chitano P., Hoidal J. R., NADPH oxidase promotes NF- B activation and proliferation in human airway smooth muscle. American Journal of Physiology 2002 282 4 L782 L795 2-s2.0-0036089393 (Pubitemid 34665595)
107. Morse D., Choi A. M. K., Heme oxygenase-1: from bench to bedside. American Journal of Respiratory and Critical Care Medicine 2005 172 6 660 670 2-s2.0-24644517828 10.1164/rccm.200404-465SO (Pubitemid 41324219)
108. Almolki A., Taillé C., Martin G. F., Jose P. J., Zedda C., Conti M., Megret J., Henin D., Aubier M., Boczkowski J., Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. American Journal of Physiology 2004 287 1 L26 L34 2-s2.0-2342529348 10.1152/ajplung.00237.2003 (Pubitemid 38787647)
109. Otterbein L. E., Kolls J. K., Mantell L. L., Cook J. L., Alam J., Choi A. M., Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. The Journal of Clinical Investigation 1999 103 7 1047 1054 10.1172/JCI5342 (Pubitemid 29169613)
110. Michaeloudes C., Chang P. J., Petrou M., Chung K. F., Transforming growth factor- β and nuclear factor E2-related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma. American Journal of Respiratory and Critical Care Medicine 2011 184 8 894 903 10.1164/rccm.201011- 1780OC